SVB Leerink Starts Selecta Biosciences (SELB) at Outperform
- Wall St ticks higher at open after selloff on jobs data
- NVIDIA (NVDA) Stock Tumbles After Weak Q2 Preliminary Results on Gaming Weakness
- JPMorgan, Morgan Stanley and Citi Discuss Outlook for US Stocks
- Vista Equity Partners to Take Avalara (AVLR) Private in an $8.4 Billion Deal
- Palantir (PLTR) Stock Tumbles 15% on Soft Outlook, Citi Sees Many Negatives
SVB Leerink analyst Joseph P. Schwartz initiates coverage on Selecta Biosciences (NASDAQ: SELB) with a Outperform rating and a price target of $7.00.
Shares of Selecta Biosciences closed at $0.88 yesterday.
You May Also Be Interested In
- UPDATE: CLSA Starts Li Auto Inc (2015:HK) (LI) at Buy (1)
- UPDATE: Ladenburg Thalmann Starts Fortress Biotech (FBIO) at Buy
- UPDATE: Stephens Starts ModivCare (MODV) at Overweight
Create E-mail Alert Related CategoriesHot New Coverage, New Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!